High gamma-aminobutyric acid level in cortical tubers in epileptic infants with tuberous sclerosis complex measured with the MEGA-editing J-difference method and a three-Tesla clinical MRI Instrument

The purpose of this study was to estimate the gamma-aminobutyric acid (GABA) and glutamate plus glutamine (Glx) concentrations in the cortical tubers of patients with tuberous sclerosis complex (TSC) using the MEGA-editing J-difference method and a stimulated echo-acquisition mode with a short echo time, and to determine which abnormality was more dominant between GABA and Glx in patients with TSC with epilepsy. This study included six patients with TSC (mean age, 4.3 years) and seven control subjects (mean age, 4.8 years). Measurements were obtained with a three-Tesla apparatus and postprocessing was conducted with an LCModel. The GABA level in the cortical gray matter (cgGABA) was calculated as a result of segmentation in voxels and from the literature values for gray and white matter ratios for GABA. Increased GABA and myo-inositol (mI) concentrations and a decreased N-acetyl aspartate (NAA) concentration were observed in the cortical tubers. The cgGABA level, and cgGABA/NAA and cgGABA/Glx ratios were also higher in patients with TSC than in control subjects. No significant difference was found in Glx concentration between patients with TSC and control subjects. Although the number of patients with TSC in this study was small, the increase in GABA and no significant change in Glx were consistent with previous neurochemical studies and support the hypothesis that brain GABA plays a key role in the pathophysiology of epilepsy during the process of neuronal development.

[1]  I. Constantinidis,et al.  MRS methodology. , 2000, Advances in neurology.

[2]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[3]  H. Hoshi,et al.  Magnetic resonance spectroscopy of tubers in patients with tuberous sclerosis , 2000, Acta neurologica Scandinavica.

[4]  C. Sarkar,et al.  Intraventricular Glioneuronal Hamartoma: Histopathological Correlation with Magnetic Resonance Spectroscopy , 2005, Journal of Neuro-Oncology.

[5]  R. Mattson,et al.  Initial Observations on Effect of Vigabatrin on In Vivo 1H Spectroscopic Measurements of γ‐Aminobutyric Acid, Glutamate, and Glutamine in Human Brain , 1995, Epilepsia.

[6]  P Boesiger,et al.  Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography. , 1999, Magnetic resonance imaging.

[7]  T. Hashimoto,et al.  DEVELOPMENTAL BRAIN CHANGES INVESTIGATED WITH PROTON MAGNETIC RESONANCE SPECTROSCOPY , 1995, Developmental medicine and child neurology.

[8]  E. Roach,et al.  Magnetic resonance imaging in tuberous sclerosis. , 1987, Archives of neurology.

[9]  Rolf Gruetter,et al.  Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: Detection of high GABA concentrations , 2006, Magnetic resonance in medicine.

[10]  Roland Kreis,et al.  Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy , 1993, Magnetic resonance in medicine.

[11]  A. Dinçer,et al.  Neurological aspects of tuberous sclerosis in relation to MRI/MR spectroscopy findings in children with epilepsy , 2007, Neurological research.

[12]  M. Garwood,et al.  Simultaneous in vivo spectral editing and water suppression , 1998, NMR in biomedicine.

[13]  Rolf Gruetter,et al.  Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference‐edited spectra , 2003, Magnetic resonance in medicine.

[14]  Roustem Khazipov,et al.  Developmental changes in GABAergic actions and seizure susceptibility in the rat hippocampus , 2004, The European journal of neuroscience.

[15]  Jun Shen,et al.  In vivo detection of gray and white matter differences in GABA concentration in the human brain , 2006, NeuroImage.

[16]  R. Mattson,et al.  Human Brain γ‐Aminobutyric Acid Levels and Seizure Control Following Initiation of Vigabatrin Therapy , 1996, Journal of neurochemistry.

[17]  R. Mattson,et al.  Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures , 1999, Seizure.

[18]  O. Houser,et al.  MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment. , 1995, AJNR. American journal of neuroradiology.

[19]  Yehezkel Ben-Ari,et al.  The multiple facets of γ-aminobutyric acid dysfunction in epilepsy: review , 2005, Current opinion in neurology.

[20]  I. Wilkinson,et al.  Proton MR spectroscopy of cortical tubers in adults with tuberous sclerosis complex. , 2001, AJNR. American journal of neuroradiology.

[21]  R. Khazipov,et al.  GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. , 2007, Physiological reviews.

[22]  Michael Garwood,et al.  Solvent Suppression Using Selective Echo Dephasing , 1996 .

[23]  Y. Ben-Ari.  Excitatory actions of gaba during development: the nature of the nurture , 2002, Nature Reviews Neuroscience.

[24]  G. Barker,et al.  Proton magnetic resonance spectroscopy of malformations of cortical development causing epilepsy , 2007, Epilepsy Research.

[25]  J. Alger,et al.  High‐Resolution Proton Magnetic Resonance Spectroscopy of Rabbit Brain: Regional Metabolite Levels and Postmortem Changes , 1988, Journal of neurochemistry.

[26]  M. Harada,et al.  Neuronal impairment of adult moyamoya disease detected by quantified proton MRS and comparison with cerebral perfusion by SPECT with tc‐99m HM‐PAO: A trial of clinical quantification of metabolites , 1999, Journal of magnetic resonance imaging : JMRI.

[27]  H. Silfvenius,et al.  Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy , 1999, Epilepsy Research.

[28]  Jens Frahm,et al.  Localized proton MRS of the human hippocampus: Metabolite concentrations and relaxation times , 1999, Magnetic resonance in medicine.

[29]  F. Hyder,et al.  GABA Changes with Vigabatrin in the Developing Human Brain , 1999, Epilepsia.

[30]  John S Duncan,et al.  A Proton Magnetic Resonance Spectroscopy Study of Metabolites in the Occipital Lobes in Epilepsy , 2003, Epilepsia.

[31]  Sanjay Kalra,et al.  Measurement of GABA and contaminants in gray and white matter in human brain in vivo , 2007, Magnetic resonance in medicine.

[32]  Blaise deB. Frederick,et al.  Grey and white matter GABA level differences in the human brain using two‐dimensional, J‐resolved spectroscopic imaging , 2005, NMR in biomedicine.